Medical directoryActive ingredient
Oral semaglutide
Oral formulation of semaglutide (Rybelsus), the first GLP-1 receptor agonist available as a tablet. In Spain it is authorised and funded by the national health service under set criteria for type 2 diabetes.
Institutional endorsement by Clínica Evolution
Medical guides
Saxenda price in Spain: the real monthly cost and how it compares
ReadRybelsus price in Spain: 1.5, 4 and 9 mg (formerly 3, 7 and 14 mg), per dose and per month
ReadOrforglipron (Foundayo): the first GLP-1 pill with no restrictions, and why it isn't available in Spain
ReadGLP-1: what it is, how it works and why it is transforming obesity treatment
Read
Keep reading
This entry is for information. Your case requires an individual medical assessment.